Novonix Sales General And Administrative To Revenue from 2010 to 2024

NVX Stock  USD 1.98  0.71  26.39%   
Novonix Sales General And Administrative To Revenue yearly trend continues to be fairly stable with very little volatility. Sales General And Administrative To Revenue will likely drop to 3.60 in 2024. During the period from 2010 to 2024, Novonix Sales General And Administrative To Revenue regression line of annual values had r-squared of  0.64 and arithmetic mean of  19.55. View All Fundamentals
 
Sales General And Administrative To Revenue  
First Reported
2010-12-31
Previous Quarter
3.78889303
Current Value
3.6
Quarterly Volatility
17.7015103
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5 M, Interest Expense of 3 M or Selling General Administrative of 16.1 M, as well as many indicators such as Price To Sales Ratio of 28.82, Dividend Yield of 0.0167 or PTB Ratio of 1.4. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
  
Check out the analysis of Novonix Correlation against competitors.

Latest Novonix's Sales General And Administrative To Revenue Growth Pattern

Below is the plot of the Sales General And Administrative To Revenue of Novonix Ltd ADR over the last few years. It is Novonix's Sales General And Administrative To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novonix's overall financial position and show how it may be relating to other accounts over time.
Sales General And Administrative To Revenue10 Years Trend
Slightly volatile
   Sales General And Administrative To Revenue   
       Timeline  

Novonix Sales General And Administrative To Revenue Regression Statistics

Arithmetic Mean19.55
Geometric Mean10.79
Coefficient Of Variation90.53
Mean Deviation16.68
Median6.53
Standard Deviation17.70
Sample Variance313.34
Range47.5805
R-Value(0.80)
Mean Square Error121.91
R-Squared0.64
Significance0.0004
Slope(3.16)
Total Sum of Squares4,387

Novonix Sales General And Administrative To Revenue History

2024 3.6
2023 3.79
2022 5.9
2021 6.53
2019 2.23
2018 3.98
2017 3.09

About Novonix Financial Statements

Novonix investors use historical fundamental indicators, such as Novonix's Sales General And Administrative To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novonix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 3.79  3.60 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.